UMN Researchers Could Soon Use Nanotechnology to Fight Cancer

When University of Minnesota researchers discovered that self-assembling nanorings were highly stable, they realized they could have a much larger effect. Nanoring therapy works by binding the nanoscopic rings to T cells. These cells then attack and kill cancer cells.

The team hopes to receive approval from the US Food and Drug Administration (FDA) to begin human trials. “Everybody [on the team] has the same goal of contributing to improving patient outcomes,” Cliff Csizmar, a PhD candidate, told the MN Daily in an interview.

Share this post

Related News

  • Couple Returns to Minnesota, This Time to Make an Impact in Medicine

    Rahel Nardos, MD, MCR, and Damien Fair, PA-C, PhD, a married faculty duo are joining the University of Minnesota Medical School in different fields of medicine.Dr. Fair serves as the co-director of the Masonic Institute for the Developing Brain, and Dr. Nardos is an associate professor in the Department of Obstetrics, Gynecology and Women’s Health and serves as a urogynecologist and director for Global Women's Health at the Center for Global Health and Social Responsibility.

  • Long-standing ‘Hand Skills Day’ Simulation Goes Virtual

    With reduced exposure to the operating room during the COVID-19 pandemic, simulated orthopedic training has helped fill in learning gaps for residents, including the department’s James House, MD, Hand Skills Lectureship and Educational Workshop.